Abstract
Systemic or topical administration of corticosteroids may produce a rise in intraocular pressure (IOP). Nonsteroidal anti-inflammatory drugs (NSAI drugs) are alternative therapy for ocular inflammatory disease. Flurbiprofen, a new NSAI drug, was tested in double-masked fashion to delineate its effect on IOP. Flurbiprofen did not alter IOP in known high corticosteroid responders nor did it block corticosteroid-induced ocular hypertension.
| Original language | English |
|---|---|
| Pages (from-to) | 831-833 |
| Number of pages | 3 |
| Journal | Annals of ophthalmology |
| Volume | 13 |
| Issue number | 7 |
| State | Published - Dec 1 1981 |